Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cilostazol (pletal) (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
peripheral blood lymphocytes (1 trial)
Cerebrovascular Disorders (Phase 3)
Chest Pain (Phase 2)
Coronary Artery Disease (Phase 2)
Infarction (Phase 2)
Ischemia (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 2)
Trials (3 total)
Trial APIs (3 total)